SOLTI Breast Cancer Research Group is a non-profit, academic organization founded in 1995, dedicated to advancing clinical and translational research in breast cancer. With a cooperative and multidisciplinary approach, SOLTI aims to develop innovative treatments and improve patient outcomes. The group brings together leading oncologists and researchers, managing a network of hospitals and research sites primarily in Spain and expanding internationally. Their research spans various subtypes of breast cancer, focusing on novel therapies, biomarkers, and personalized medicine.
The headquarters serves as the central administrative and operational hub, coordinating clinical trials, managing data, fostering scientific collaboration, and overseeing strategic initiatives for the research group.
Likely a modern office environment equipped with advanced technology to support complex research coordination, data analysis, and international communication. The location in Barcelona provides access to a rich ecosystem of research institutions and talent.
SOLTI's work culture is characterized by a strong commitment to its mission, scientific rigor, collaboration among multidisciplinary teams, and a patient-centric approach. It fosters an environment of innovation and continuous learning.
The Barcelona headquarters is crucial for orchestrating SOLTI's extensive network of over 400 researchers and 100 associated hospitals, making it a key center for breast cancer research advancement in Spain and a significant contributor to international research efforts.
While SOLTI's main coordinating office is in Barcelona, its global presence is manifested through its extensive collaborative network. SOLTI conducts clinical trials and research projects in numerous hospitals and research centers across Spain, Portugal, France, Italy, Germany, Belgium, Ireland, United Kingdom and the USA. This network allows for diverse patient populations in trials and broad dissemination of research findings, supporting functions like multi-center clinical trial management, international research collaboration, and data sharing.
C/ Balmes 89, 2º 2ª
Barcelona
Catalonia
Spain
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, SOLTI Breast Cancer Research Group' leadership includes:
SOLTI Breast Cancer Research Group has been backed by several prominent investors over the years, including:
SOLTI's leadership team has remained largely stable, with a key internal appointment enhancing its research capabilities. No major executive departures have been publicly reported in the last 12 months.
Discover the tools SOLTI Breast Cancer Research Group uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
SOLTI likely uses a common professional email format for its staff, typically combining an initial and last name or full name with their domain. Based on publicly available contact information for team members, the primary format appears to be the first initial followed by the last name.
[first_initial][last_name]@solti.org
Format
jdoe@solti.org (example for Jane Doe)
Example
75%
Success rate
SOLTI Website News • May 30, 2024
SOLTI shared updated results from its ACROPIX clinical trial at the American Society of Clinical Oncology (ASCO) Annual Meeting, focusing on a novel treatment combination for HR+/HER2- advanced breast cancer....more
SOLTI Website News • December 6, 2023
SOLTI showcased findings from three distinct research studies at SABCS 2023, highlighting advancements in areas such as liquid biopsy and treatment strategies for different breast cancer subtypes....more
SOLTI Website News • November 13, 2023
SOLTI initiated its HOPE clinical trial, an international study aimed at evaluating a new therapeutic approach for patients with metastatic breast cancer, marking a step forward in its research pipeline....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including SOLTI Breast Cancer Research Group, are just a search away.